Keyphrases
Pluronic Nanoparticles
100%
Glycol chitosan
100%
Paclitaxel
100%
Heparin
100%
Targeting Capability
100%
Composite Nanoparticles
57%
Tumor Targeting
42%
Nanoparticles
28%
Pluronic F68
28%
Freeze-drying
14%
Particle Size Analysis
14%
Release Pattern
14%
Delivery System
14%
Anticancer Drugs
14%
Tail Vein
14%
Aqueous Media
14%
Tumor Growth
14%
Tumor-bearing Mice
14%
Field Emission Scanning Electron Microscopy (FE-SEM)
14%
Polyethylene Glycol
14%
Temperature-induced Phase Transition
14%
Pharmacokinetic Parameters
14%
Solubilizer
14%
In Vivo Biodistribution
14%
Excretion Profile
14%
Polyethylene Glycol Molecular Weight
14%
Circulation Time
14%
Nanoparticle Composites
14%
Imaging Technology
14%
Live Animal Imaging
14%
Pharmacology, Toxicology and Pharmaceutical Science
Poloxamer
100%
Nanoparticle
100%
Chitosan
100%
Paclitaxel
100%
Heparin
100%
Neoplasm
36%
Macrogol
18%
Anticarcinogen
9%
Tumor Growth
9%
Biodistribution
9%
Solubilizer
9%
Pharmacokinetic Parameter
9%
Field Emission Scanning Electron Microscopy
9%